BOOK
Heterotrophic Plate Counts and Drinking-water Safety
Jamie Bartram | J. A. Cotruvo | M. Exner | C. Fricker | A. Glasmacher
(2003)
Additional Information
Book Details
Abstract
Heterotrophic Plate Counts and Drinking-water Safety provides a critical assessment of the role of the Heterotrophic Plate Count (HPC) measurement in drinking water quality management. It was developed from an Expert workshop of 32 scientists convened by the World Health Organization and the WHO/NSF International Collaborating Centre for Drinking Water Safety and Treatment in Geneva, Switzerland. Heterotrophs are organisms, including bacteria, yeasts and moulds, that require an external source of organic carbon for growth. The HPC test (or Standard Plate Count), applied in many variants, is the internationally accepted test for measuring the hetrotrophic microorganism population in drinking water, and also other media. It measures only a fraction of the microorganisms actually present and does not distinguish between pathogens and non-pathogens. High levels of microbial growth can affect the taste and odor of drinking water and may indicate the presence of nutrients and biofilms which could harbor pathogens, as well as the possibility that some event has interfered with the normal production of the drinking water. HPC counts also routinely increase in water that has been treated by an in-line device such as a carbon filter or softener, in water-dispensing devices and in bottled waters and indeed in all water that has suitable nutrients, does not have a residual disinfectant, and is kept under sufficient conditions. There is debate among health professionals as to the need, utility or quantitative basis for health-based standards or guidelines relating to HPC-measured regrowth in drinking water.  The issues that were addressed in this work include: the relationship between HPC in drinking water (including that derived from in-line treatment systems, dispensers and bottled water) and health risks for the general public                         the role of HPC as an indirect indicator or index for pathogens of concern in drinking water                        the role of HPC in assessing the efficacy and proper functioning of water treatment and supply processes                        the relationship between HPC and the aesthetic acceptability of drinking water. Heterotrophic Plate Counts and Drinking-water Safety provides valuable information on the utility and the limitations of HPC data in the management and operation of piped water systems as well as other means of providing drinking water to the public. It is of particular value to piped public water suppliers and bottled water suppliers, manufacturers and users of water treatment and transmission equipment and inline treatment devices, water engineers, sanitary and clinical microbiologists, and national and local public health officials and regulators of drinking water quality.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Cover\r | Cover | ||
Contents | v | ||
Foreword | vii | ||
Acknowledgements | ix | ||
List of acronyms and abbreviations | xi | ||
Robert Koch | xiv | ||
1:\rExpert consensus | 1 | ||
1.1 DEFINITIONS AND SCOPE\r | 1 | ||
1.1.1 Drinking-water | 1 | ||
1.1.2 Heterotrophic plate count | 2 | ||
1.1.3 Microbial growth in water | 2 | ||
1.1.4 Use of HPC in water management | 3 | ||
1.2 USES IN PIPED WATER SUPPLIES\r | 3 | ||
1.2.1 Water safety plans | 3 | ||
1.2.2 Water quality targets | 4 | ||
1.2.3 Validation and verification | 4 | ||
1.2.4 Aesthetic quality | 5 | ||
1.3 USES IN NON-PIPED AND OTHER WATER SUPPLIES\r | 6 | ||
1.3.1 Bottled water | 6 | ||
1.3.2 Plumbed-in devices | 6 | ||
1.3.3 Conveyances | 6 | ||
1.3.4 Other water exposure media | 7 | ||
1.4 HEALTH ASPECTS\r | 7 | ||
1.4.1 Exposure | 7 | ||
1.4.2 Epidemiology | 7 | ||
1.4.3 Health effects — specific organisms | 8 | ||
1.4.4 Populations at increased risk (including sensitivity through life stages) | 8 | ||
1.4.5 Health care facilities | 9 | ||
1.5 OUTSTANDING QUESTIONS AND RESEARCH | 9 | ||
1.6 REFERENCES | 10 | ||
2: Public health aspects of the role of\rHPC — an introduction | 12 | ||
2.1 INTRODUCTION | 12 | ||
2.2 HISTORICAL ASPECTS | 13 | ||
2.3 RECENT DEVELOPMENTS | 14 | ||
2.3.1 New procedure for determining colony counts | 15 | ||
2.3.2 Biofilms | 15 | ||
2.3.3 Risks from bacteria detected in water | 15 | ||
2.4 ALTERED BASIC CONDITIONS | 17 | ||
2.4.1 The scope of national drinking-water regulations | 17 | ||
2.4.2 Regulations for water quality in high-risk areas | 18 | ||
2.4.3 Changes in sociodemographic conditions | 18 | ||
2.5 REFERENCES | 18 | ||
3:\rThe history and use of HPC in drinking-water quality management | 20 | ||
3.1 INTRODUCTION | 20 | ||
3.2 GERMS AND DISEASE: FROM DISCOVERY TO CULTIVATION | 21 | ||
3.3 KOCH: ASSESSING FILTER EFFICIENCY AND SETTING LIMITS | 22 | ||
3.4 WATER MICROBIOLOGY: THE UNITED KINGDOM EXAMPLE\r | 23 | ||
3.4.1 Early water microbiology | 23 | ||
3.4.2 Early use of heterotrophic plate counts (HPC) | 25 | ||
3.4.3 Guidance on the use of HPC | 26 | ||
3.4.4 Interpretation of HPC levels | 26 | ||
3.4.5 Current use of HPC in the United Kingdom | 28 | ||
3.5 THE AMERICAN PERSPECTIVE ON THE PLATE COUNT\r | 29 | ||
3.5.1 Early water bacteriology in the USA | 29 | ||
3.5.2 Measuring HPC microorganisms in the USA | 33 | ||
3.5.3 Interference with the total coliform assay | 34 | ||
3.6 OPPORTUNISTIC PATHOGENS AND HEALTH EFFECTS | 35 | ||
3.7 HEALTH EFFECTS: EPIDEMIOLOGICAL STUDY | 38 | ||
3.8 HPC BACTERIA IN FOOD | 39 | ||
3.9 MANDATORY OR GUIDELINE HPC VALUES IN THE 1970S AND 1980S | 41 | ||
3.10 STANDARDS AND GUIDELINES IN THE 1990S | 42 | ||
3.11 CONCLUSIONS | 42 | ||
3.12 REFERENCES | 45 | ||
4:\rThe presence of bacteria in water after regrowth | 49 | ||
4.1 INTRODUCTION | 49 | ||
4.2 DETECTION OF BACTERIA IN WATER | 50 | ||
4.3 THE “VIABLE BUT NON-CULTURABLE” STATE | 51 | ||
4.4 MICROBIOLOGICAL REGROWTH | 51 | ||
4.5 MICROBIAL PATHOGENS IN WATER | 52 | ||
4.5.1 Aeromonas spp. | 53 | ||
4.5.2 Pseudomonas | 54 | ||
4.5.3 Mycobacterium avium complex (MAC) | 54 | ||
4.5.4 Other microorganisms | 54 | ||
4.6 REGROWTH OF BACTERIA IN POINT-OF-USE AND POINT-OF-ENTRY DEVICES | 55 | ||
4.7 POTENTIAL BENEFICIAL EFFECTS OF REGROWTH | 56 | ||
4.8 THE EFFECT OF AUTO-DISINFECTION OF POU DEVICES | 57 | ||
4.9 CONCLUSIONS | 58 | ||
4.10 REFERENCES | 58 | ||
5:\rBacteria of potential health concern | 61 | ||
5.1 INTRODUCTION | 61 | ||
5.2 COMMENSAL BACTERIA | 62 | ||
5.2.1 Aeromonas | 62 | ||
5.2.2 Yersinia | 64 | ||
5.2.3 Klebsiella | 64 | ||
5.2.4 Pseudomonas | 65 | ||
5.2.5 Virulence factors | 65 | ||
5.2.6 Hospital-acquired infection | 66 | ||
5.3 RECOGNIZED WATERBORNE PATHOGENS | 66 | ||
5.3.1 Campylobacter | 68 | ||
5.3.2 Escherichia coli | 69 | ||
5.3.3 Salmonella | 70 | ||
5.3.4 Shigella | 71 | ||
5.3.5 Vibrio | 71 | ||
5.4 EMERGING PATHOGENS | 72 | ||
5.4.1 Helicobacter pylori | 72 | ||
5.4.2 Mycobacterium | 73 | ||
5.4.3 Burkholderia pseudomallei | 74 | ||
5.4.4 Francisella tularensis | 74 | ||
5.5 BIOTERRORISM THREAT AGENTS | 75 | ||
5.6 CONCLUSIONS | 75 | ||
5.7 REFERENCES | 77 | ||
6:\rRelationships between common water bacteria and pathogens in drinking-water | 80 | ||
6.1 INTRODUCTION | 80 | ||
6.2 HETEROTROPHIC BACTERIA AS INHABITANTS OF A DRINKING-WATER ECOSYSTEM | 81 | ||
6.2.1 Biofilm | 82 | ||
6.2.2 Starvation-survival lifestyle | 84 | ||
6.2.3 The viable but non-culturable state | 86 | ||
6.3 WHAT IS A PATHOGEN IN DRINKING-WATER? | 86 | ||
6.3.1 Pseudomonas aeruginosa\r | 90 | ||
6.3.2 Aeromonas\r | 91 | ||
6.3.3 Legionella | 92 | ||
6.3.4 Mycobacterium avium complex (MAC) | 93 | ||
6.3.5 Helicobacter pylori | 94 | ||
6.4 HETEROTROPHIC BACTERIA IN DISTRIBUTION SYSTEMS AND PATHOGENS | 94 | ||
6.4.1 Spatial and temporal heterogeneity in the pipe network | 94 | ||
6.4.2 Biological heterogeneity and instability | 95 | ||
6.4.3 Diversity of bacterial stresses | 97 | ||
6.4.4 Interactions between heterotrophic bacteria and pathogens | 97 | ||
6.4.4.1 E. coli as a model of enteric bacteria | 98 | ||
6.4.4.2 Pathogens growing in water | 99 | ||
6.5 HETEROTROPHIC BACTERIA IN NATURAL MINERAL WATER AND PATHOGENS | 100 | ||
6.5.1 Bottle habitat | 101 | ||
6.5.1.1 The bottle effect | 101 | ||
6.5.1.2 Attached versus unattached bacteria | 102 | ||
6.5.1.3 Growth or resuscitation | 102 | ||
6.5.2 Microbial community | 103 | ||
6.5.2.1 Gram-negative bacteria | 103 | ||
6.5.2.2 Gram-positive bacteria | 105 | ||
6.5.2.3 Identified bacteria by rRNA-targeted oligonucleotide probes | 106 | ||
6.5.2.4 Bacterial microdiversity | 106 | ||
6.5.3 Fate of pathogens in natural mineral water | 106 | ||
6.5.3.1 Enteric bacteria | 107 | ||
6.5.3.2 Pathogenic bacteria growing in water | 107 | ||
6.5.4 Assessing health risk from autochthonous bacteria | 109 | ||
6.5.4.1 Animal model system | 110 | ||
6.5.4.2 Randomized trial in infants | 110 | ||
6.5.4.3 Virulence characteristics of bacteria | 110 | ||
6.6 CONCLUSIONS | 111 | ||
6.7 REFERENCES | 113 | ||
7:\rEpidemiological and riskassessment evidence of diseaselinked to HPC bacteria | 119 | ||
7.1 INTRODUCTION | 119 | ||
7.2 EPIDEMIOLOGICAL STUDIES OF HUMAN ILLNESS AND HPC | 121 | ||
7.3 EPIDEMIOLOGICAL STUDIES OF DISEASE DUE TO BACTERIA THAT MAY BE PART OF THE HPC FLORA | 122 | ||
7.3.1 Mycobacteria | 123 | ||
7.3.2 Aeromonas | 124 | ||
7.3.3 Pseudomonas aeruginosa | 125 | ||
7.3.4 Legionella | 127 | ||
7.3.5 Other HPC bacteria | 127 | ||
7.4 RISK ASSESSMENT | 128 | ||
7.4.1 Hazard identification | 129 | ||
7.4.2 Exposure assessment | 130 | ||
7.4.3 Dose–response assessment | 130 | ||
7.4.4 Risk categorization | 131 | ||
7.5 CONCLUSIONS | 132 | ||
7.6 REFERENCES | 133 | ||
8:\rInfections from HPC organisms in drinking-water amongst the immunocompromised | 137 | ||
8.1 INTRODUCTION | 137 | ||
8.2 EPIDEMIOLOGY AND PATHOPHYSIOLOGY OF IMMUNODEFICIENCY | 138 | ||
8.3 THE SETTING OF CARE FOR IMMUNOCOMPROMISED PATIENTS | 139 | ||
8.4 INFECTIOUS RISKS FOR AMBULATORY IMMUNOCOMPROMISED PATIENTS | 140 | ||
8.5 FUNGAL INFECTIONS FROM WATER SYSTEMS | 140 | ||
8.6 RISK ASSESSMENT OF OPPORTUNISTIC BACTERIAL PATHOGENS | 141 | ||
8.7 RISK ASSESSMENT FOR INFECTION FROM WATER | 142 | ||
8.8 STAGES OF IMMUNOSUPPRESSION AND APPROPRIATE PROTECTION MEASURES | 143 | ||
8.9 THE PRECAUTIONARY PRINCIPLE | 144 | ||
8.10 REFERENCES | 144 | ||
9:\rMethods to identify and enumerate frank and opportunistic bacterial pathogens in water and biofilms | 146 | ||
9.1 INTRODUCTION | 146 | ||
9.2 WATER OR BIOFILM SAMPLING FOR PATHOGENS | 149 | ||
9.3 CULTURE-BASED (TRADITIONAL) METHODS | 150 | ||
9.4 CONCENTRATION OF TARGET BACTERIA | 150 | ||
9.5 GROWTH AND DETECTION WITH CHROMOGENIC SUBSTANCES | 153 | ||
9.6 IMMUNOLOGICAL AND NUCLEIC ACID-BASED METHODS | 153 | ||
9.6.1 Antibody-based methods | 153 | ||
9.6.2 Immunomagnetic separation | 154 | ||
9.6.3 Gene sequence-based methods | 155 | ||
9.6.4 Polymerase chain reaction | 155 | ||
9.6.5 Fluorescence | 158 | ||
9.7 FINGERPRINTING METHODS | 159 | ||
9.7.1 Ribotyping | 159 | ||
9.7.2 Profiling of low-molecular-weight RNA | 160 | ||
9.7.3 Restriction fragment length polymorphism | 161 | ||
9.7.4 Amplified fragment length polymorphisms and arbitrarily primed PCR | 162 | ||
9.7.5 Repetitive gene PCR | 163 | ||
9.7.6 Denaturing and temperature gradient gel electrophoresis | 163 | ||
9.7.7 Single-strand conformation polymorphism | 164 | ||
9.8 EMERGING METHODS | 165 | ||
9.9 CONCLUSIONS | 167 | ||
9.10 REFERENCES | 168 | ||
10:\rConditions favouring coliform and HPC bacterial growth in drinkingwater and on water contact surfaces | 177 | ||
10.1 INTRODUCTION | 177 | ||
10.2 GROWTH OF COLIFORM AND HPC BACTERIA IN WATER | 179 | ||
10.2.1 Filtration | 179 | ||
10.2.2 Temperature | 179 | ||
10.2.3 Disinfectant residual and disinfectant level | 179 | ||
10.2.4 AOC and BDOC levels | 181 | ||
10.2.5 Corrosion control and pipe materials | 184 | ||
10.2.6 Residence time | 189 | ||
10.3:\rBIOFILM CONTROL FOR BACTERIA OF POTENTIAL PUBLIC HEALTH SIGNIFICANCE | 189 | ||
10.3.1 Mycobacterium avium complex\r | 189 | ||
10.3.2 Legionella | 193 | ||
10.3.3 Other organisms | 193 | ||
10.4 CONCLUSIONS | 193 | ||
10.5 REFERENCES | 194 | ||
11:\rManaging regrowth in drinkingwater distribution systems | 199 | ||
11.1 INTRODUCTION | 199 | ||
11.2 PROBLEMS RELATED TO MICROBIAL ACTIVITY\r | 200 | ||
11.2.1 Regrowth, biofilms and microbial activity | 200 | ||
11.2.2 Coliforms | 201 | ||
11.2.3 Opportunistic pathogens | 201 | ||
11.2.4 Increased HPC values | 203 | ||
11.2.5 Nuisance organisms | 204 | ||
11.3 ASSESSMENT OF MICROBIAL ACTIVITY\r | 205 | ||
11.3.1 Monitoring tools needed | 205 | ||
11.3.2 Heterotrophic plate counts | 206 | ||
11.3.3 Total direct counts | 206 | ||
11.3.4 Adenosine triphosphate | 207 | ||
11.3.5 Other methods | 208 | ||
11.3.6 Suite of methods | 209 | ||
11.4 FACTORS PROMOTING MICROBIAL ACTIVITY\r | 210 | ||
11.4.1 Energy sources in water | 210 | ||
11.4.1.1 Power of multiplication | 210 | ||
11.4.1.2 Assimilable organic carbon | 211 | ||
11.4.1.3 Biodegradable dissolved organic carbon | 212 | ||
11.4.1.4 Biofilm formation rate | 213 | ||
11.4.2 Materials and sediments | 213 | ||
11.4.2.1 Materials | 213 | ||
11.4.2.2 Sediments and corrosion products | 214 | ||
11.4.3 Temperature and hydraulic conditions | 214 | ||
11.4.4 Models | 215 | ||
11.4.5 Biological stability | 215 | ||
11.4.6 Suite of tools | 217 | ||
11.5 CONTROLLING MICROBIAL ACTIVITY\r | 217 | ||
11.5.1 General | 217 | ||
11.5.2 Biological stability | 217 | ||
11.5.2.1 Water treatment | 217 | ||
11.5.2.2 Materials | 219 | ||
11.5.3 Disinfection | 219 | ||
11.5.3.1 Chlorine | 219 | ||
11.5.3.2 Monochloramine | 220 | ||
11.5.4 Distribution system configuration and maintenance | 221 | ||
11.5.5 Multiple barriers against microbial activity in distribution systems | 221 | ||
11.6 REFERENCES | 222 | ||
12:\rThe role of HPC in managing the treatment and distribution of drinking-water | 233 | ||
12.1 INTRODUCTION | 233 | ||
12.2 HPC BACTERIA IN WATER TREATMENT PLANTS | 234 | ||
12.3 HPC BACTERIA IN WATER DISTRIBUTION SYSTEMS | 235 | ||
12.4 HPC BACTERIA IN WATER TREATMENT DEVICES | 236 | ||
12.5 HPC BACTERIA IN BOTTLED WATER | 237 | ||
12.6 STANDARDS AND GUIDELINES | 238 | ||
12.6.1 World Health Organization (WHO) guidelines | 238 | ||
12.6.2 European guidelines | 239 | ||
12.6.3 United Kingdom regulations | 239 | ||
12.6.4 German regulations | 240 | ||
12.6.5 Canadian guidelines | 240 | ||
12.6.6 Regulations in the USA | 241 | ||
12.6.7 Australian guidelines | 242 | ||
12.6.8 Regulations in other countries | 242 | ||
12.7 CONCLUSIONS | 242 | ||
12.8 REFERENCES | 243 | ||
Index | 245 |